Research study Program year 2020 Source: CMS Open Payments

A Phase IV, 12 Week, Randomised, Double-Blind, Double-Dummy Study to C

Research payments

$1,270,664

213 payments

Through program year 2020, $1,270,664 in research payments was reported against A Phase IV, 12 Week, Randomised, Double-Blind, Double-Dummy Study to C, across 213 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$133,360	41
2019	Research	$1,137,304	172

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $1,270,664 213 payments

Who received the money Research payments · program years 2019–2020

Abrh LLC Organisation paid for research $374,343 69 payments
Jesscan Medical Research Organisation paid for research $297,277 4 payments
San Marcus Research Clinic INC Organisation paid for research $154,854 3 payments
Florida Institute For Clinical Research Organisation paid for research $49,623 26 payments
Clinical Research Of Gastonia Organisation paid for research $45,599 4 payments
Asr LLC Organisation paid for research $37,784 6 payments
Minnesota Lung Center Organisation paid for research $37,672 8 payments
Clinical Research Associates Of Central PA LLC Organisation paid for research $34,054 3 payments
Clinical Trial Source Organisation paid for research $30,971 5 payments
MD Medical Research Ong Medical Center Organisation paid for research $23,379 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.